Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.35 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5854880 | 0.94 | USP2 (0.55) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL11042040 | 0.85 | USP2 (0.75) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL8619644 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL3108971 | 0.83 | USP2 (0.72) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL8620507 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL8622815 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL8622282 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL29837928 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL6230528 | 0.83 | USP2 (0.79) | USP2HTTPLA2G2CLPAR5CYP1A2 | |
| SCHEMBL101143 | 0.80 | USP2 (0.68) | USP2HTTPLA2G2CLPAR5CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098044-A1 | SOLID PARTICLES FROM CONTROLLED DESTABILISATION OF MICROEMULSIONS | AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098044-A1 | SOLID PARTICLES FROM CONTROLLED DESTABILISATION OF MICROEMULSIONS | AUP1, NCAPD2, CHMP4B | USP2 656/4885HTT 673/4885PLA2G2C 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.